E Altmann

608 total citations
23 papers, 445 citations indexed

About

E Altmann is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, E Altmann has authored 23 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Internal Medicine. Recurrent topics in E Altmann's work include Heart Failure Treatment and Management (7 papers), Acute Myocardial Infarction Research (7 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). E Altmann is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Acute Myocardial Infarction Research (7 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). E Altmann collaborates with scholars based in Germany. E Altmann's co-authors include Jochen Senges, Martin Gottwik, Karlheinz Seidl, Ralf Zahn, Steffen Schneider, Rudolf Schiele, Anselm K. Gitt, Harm Wienbergen, Johannes Schweizer and Thomas Voigtländer and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

E Altmann

22 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Altmann Germany 9 303 182 130 70 57 23 445
Kaoru Asada Japan 10 300 1.0× 52 0.3× 158 1.2× 19 0.3× 16 0.3× 15 450
Shlomo Laniado Israel 8 309 1.0× 66 0.4× 62 0.5× 18 0.3× 36 0.6× 8 434
M. O. Evseev Georgia 7 227 0.7× 109 0.6× 64 0.5× 99 1.4× 18 0.3× 9 339
W N Hubbard United Kingdom 10 214 0.7× 102 0.6× 89 0.7× 36 0.5× 26 0.5× 13 330
H. Joel Gorfinkel United States 8 243 0.8× 284 1.6× 149 1.1× 7 0.1× 18 0.3× 15 461
Douglas B. Bogart United States 10 200 0.7× 138 0.8× 51 0.4× 59 0.8× 12 0.2× 25 364
Joana Silva Portugal 11 156 0.5× 144 0.8× 72 0.6× 20 0.3× 27 0.5× 90 390
Charles de Riberolles France 10 144 0.5× 143 0.8× 39 0.3× 15 0.2× 30 0.5× 31 274
Gopikrishna Punukollu United States 11 272 0.9× 64 0.4× 49 0.4× 108 1.5× 23 0.4× 14 422
Jubin Joseph United Kingdom 11 399 1.3× 97 0.5× 77 0.6× 19 0.3× 45 0.8× 27 577

Countries citing papers authored by E Altmann

Since Specialization
Citations

This map shows the geographic impact of E Altmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Altmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Altmann more than expected).

Fields of papers citing papers by E Altmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Altmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Altmann. The network helps show where E Altmann may publish in the future.

Co-authorship network of co-authors of E Altmann

This figure shows the co-authorship network connecting the top 25 collaborators of E Altmann. A scholar is included among the top collaborators of E Altmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Altmann. E Altmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schellong, Sebastian, et al.. (2004). Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia. Prostaglandins Leukotrienes and Essential Fatty Acids. 70(6). 503–509. 6 indexed citations
2.
Zahn, Ralf, Steffen Schneider, Karlheinz Seidl, et al.. (2003). Antibiotic Therapy After Acute Myocardial Infarction. Circulation. 107(9). 1253–1259. 75 indexed citations
3.
Zahn, Ralf, Rudolf Schiele, Steffen Schneider, et al.. (2001). Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty?. Journal of the American College of Cardiology. 37(7). 1827–1835. 88 indexed citations
4.
5.
Zahn, Ralf, Rudolf Schiele, Anselm K. Gitt, et al.. (2001). Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. American Heart Journal. 142(1). 105–111. 38 indexed citations
6.
Zahn, Ralf, Rudolf Schiele, Simon Schneider, et al.. (2001). Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR).. PubMed. 13(5). 367–72. 15 indexed citations
7.
Zahn, Ralf, Anselm K. Gitt, Harm Wienbergen, et al.. (2000). Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Journal of the American College of Cardiology. 36(7). 2064–2071. 57 indexed citations
8.
9.
Zahn, Ralf, Rudolf Schiele, Steffen Schneider, et al.. (2000). Transfer of Patients with Acute Myocardial Infarction for Primary or Acute Angioplasty from Hospitals without the Facilities to Perform Angioplasty. 2 indexed citations
10.
Wagner, Simon D., Sven Schneider, Rudolf Schiele, et al.. (1999). Akuter Myokardinfarkt in Deutschland im Zeitraum zwischen 1996 und 1998: Therapie und hospitaler Verlauf Ergebnisse des Myokardinfarktregisters (MIR) in Deutschland. Zeitschrift für Kardiologie. 88(10). 857–867. 42 indexed citations
11.
Altmann, E, et al.. (1998). A Rare Complication with an Anthéor Vena Cava Filter. CardioVascular and Interventional Radiology. 21(2). 165–167. 18 indexed citations
12.
Schweizer, Johannes, et al.. (1997). Beta-blockers and nitrates in patients with peripheral arterial occlusive disease: long-term findings.. PubMed. 26(1). 43–6. 8 indexed citations
13.
Schweizer, Johannes, et al.. (1996). Comparison of tissue plasminogen activator and urokinase in the local infiltration thrombolysis of peripheral arterial occlusions. European Journal of Radiology. 22(2). 129–132. 42 indexed citations
14.
Krappweis, Jutta, et al.. (1996). Digitoxin intoxication with lethal outcome.. PubMed. 1(12). 551–3.
15.
Schweizer, Johannes, et al.. (1996). [Are beta-blockers generally contraindicated in patients with peripheral arterial occlusive disease?].. PubMed. 85(3). 193–7. 2 indexed citations
16.
Schweizer, Johannes, et al.. (1993). [Color-coded duplex ultrasound and contrast medium enhanced duplex ultrasound in deep venous thrombosis].. PubMed. 22(1). 22–5. 1 indexed citations
17.
Schweizer, Johannes, et al.. (1991). [Early complications after acute cerebrovascular insufficiency].. PubMed. 46(1-2). 49–51. 1 indexed citations
18.
Schweizer, Johannes, et al.. (1991). [Experiences with the Günther filter].. PubMed. 46(13). 483–5. 1 indexed citations
19.
Schweizer, Johannes, et al.. (1990). [Doppler sonography in the diagnosis of extracranial vascular changes].. PubMed. 45(20). 609–11. 1 indexed citations
20.
Klemm, E., E Altmann, & O. Lange. (1983). [Rheologic problems of microcirculation and consequences of drug therapy for sudden deafness].. PubMed. 62(2). 62–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaoru Asada Breakdown of academic impact, for papers by Shlomo Laniado Breakdown of academic impact, for papers by M. O. Evseev Breakdown of academic impact, for papers by W N Hubbard Breakdown of academic impact, for papers by H. Joel Gorfinkel Breakdown of academic impact, for papers by Douglas B. Bogart Breakdown of academic impact, for papers by Joana Silva Breakdown of academic impact, for papers by Charles de Riberolles Breakdown of academic impact, for papers by Gopikrishna Punukollu Breakdown of academic impact, for papers by Jubin Joseph
Rankless by CCL
2026